Stay updated on BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include the term 'Rheumatoid Arthritis' and the product name 'BIORA (BCD-020-2)', while the previous detailed study description has been removed, along with the revision number change from v2.14.4 to v2.15.0.SummaryDifference33%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1.0%
Stay in the know with updates to BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-020 vs MabThera in Rheumatoid Arthritis Clinical Trial page.